HCTI Fundamental Analysis - HEALTHCARE TRIANGLE INC

Fundamental Rating

Taking everything into account, HCTI scores 2 out of 10 in our fundamental rating. HCTI was compared to 35 industry peers in the Health Care Technology industry. HCTI has a bad profitability rating. Also its financial health evaluation is rather negative. HCTI does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

HCTI had negative earnings in the past year.

In the past year HCTI has reported a negative cash flow from operations.

HCTI had negative earnings in 4 of the past 5 years.

In the past 5 years HCTI always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -45.69%, HCTI is not doing good in the industry: 65.71% of the companies in the same industry are doing better.

Looking at the Return On Equity, with a value of -72.30%, HCTI is doing worse than 68.57% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-45.69%
ROE	-72.3%
ROIC	N/A

ROA(3y)-159.11%

ROA(5y)-96.07%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of HCTI (13.11%) is worse than 88.57% of its industry peers.

HCTI's Gross Margin has improved in the last couple of years.

HCTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	13.11%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.08%

GM growth 5Y3.95%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HCTI does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for HCTI has been increased compared to 1 year ago.

The number of shares outstanding for HCTI has been increased compared to 5 years ago.

HCTI has a worse debt/assets ratio than last year.

2.2 Solvency

HCTI has an Altman-Z score of -3.61. This is a bad value and indicates that HCTI is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of HCTI (-3.61) is worse than 71.43% of its industry peers.

A Debt/Equity ratio of 0.17 indicates that HCTI is not too dependend on debt financing.

With a Debt to Equity ratio value of 0.17, HCTI perfoms like the industry average, outperforming 42.86% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.17
Debt/FCF	N/A
Altman-Z	-3.61

ROIC/WACCN/A

WACC8.44%

2.3 Liquidity

A Current Ratio of 2.03 indicates that HCTI has no problem at all paying its short term obligations.

HCTI's Current ratio of 2.03 is in line compared to the rest of the industry. HCTI outperforms 48.57% of its industry peers.

HCTI has a Quick Ratio of 1.98. This is a normal value and indicates that HCTI is financially healthy and should not expect problems in meeting its short term obligations.

HCTI's Quick ratio of 1.98 is in line compared to the rest of the industry. HCTI outperforms 48.57% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.03
Quick Ratio	1.98

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HCTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.53%, which is quite impressive.

HCTI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.88%.

Measured over the past years, HCTI shows a very negative growth in Revenue. The Revenue has been decreasing by -16.46% on average per year.

EPS 1Y (TTM)81.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.22%

Revenue 1Y (TTM)-21.88%

Revenue growth 3Y-30.78%

Revenue growth 5Y-16.46%

Sales Q2Q%44.59%

3.2 Future

The Earnings Per Share is expected to grow by 43.35% on average over the next years. This is a very strong growth

Based on estimates for the next years, HCTI will show a very negative growth in Revenue. The Revenue will decrease by -12.97% on average per year.

EPS Next Y-1933.33%

EPS Next 2Y-142.67%

EPS Next 3Y-34.71%

EPS Next 5Y43.35%

Revenue Next Year-72.5%

Revenue Next 2Y-36.88%

Revenue Next 3Y-21.81%

Revenue Next 5Y-12.97%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HCTI. In the last year negative earnings were reported.

Also next year HCTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as HCTI's earnings are expected to decrease with -34.71% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-142.67%

EPS Next 3Y-34.71%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

HCTI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

HEALTHCARE TRIANGLE INC

NASDAQ:HCTI (1/8/2026, 8:00:02 PM)

After market: 0.54 0 (-0.9%)

0.5449

-0.02 (-4.15%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)11-13 2025-11-13/bmo

Earnings (Next)N/A N/A

Inst Owners10.88%

Inst Owner Change0%

Ins OwnersN/A

Ins Owner Change0%

Market Cap3.20M

Revenue(TTM)12.94M

Net Income(TTM)-6.32M

Analysts82.86

Price Target5.1 (835.95%)

Short Float %7.38%

Short Ratio1.06

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)233.33%

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.25
P/FCF	N/A
P/OCF	N/A
P/B	0.37
P/tB	1.12
EV/EBITDA	N/A

EPS(TTM)-103.12

EYN/A

EPS(NY)-0.54

Fwd EYN/A

FCF(TTM)-2.01

FCFYN/A

OCF(TTM)-1.79

OCFYN/A

SpS2.2

BVpS1.49

TBVpS0.49

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-45.69%
ROE	-72.3%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	13.11%
FCFM	N/A

ROA(3y)-159.11%

ROA(5y)-96.07%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.08%

GM growth 5Y3.95%

F-Score3

Asset Turnover0.94

Health

		Industry Rank	Sector Rank
Debt/Equity	0.17
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.03
Quick Ratio	1.98
Altman-Z	-3.61

F-Score3

WACC8.44%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)81.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.22%

EPS Next Y-1933.33%

EPS Next 2Y-142.67%

EPS Next 3Y-34.71%

EPS Next 5Y43.35%

Revenue 1Y (TTM)-21.88%

Revenue growth 3Y-30.78%

Revenue growth 5Y-16.46%

Sales Q2Q%44.59%

Revenue Next Year-72.5%

Revenue Next 2Y-36.88%

Revenue Next 3Y-21.81%

Revenue Next 5Y-12.97%

EBIT growth 1Y36.96%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-132.07%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-107.51%

OCF growth 3YN/A

OCF growth 5YN/A

HEALTHCARE TRIANGLE INC / HCTI FAQ

Can you provide the ChartMill fundamental rating for HEALTHCARE TRIANGLE INC?

ChartMill assigns a fundamental rating of 2 / 10 to HCTI.

Can you provide the valuation status for HEALTHCARE TRIANGLE INC?

ChartMill assigns a valuation rating of 0 / 10 to HEALTHCARE TRIANGLE INC (HCTI). This can be considered as Overvalued.

How profitable is HEALTHCARE TRIANGLE INC (HCTI) stock?

HEALTHCARE TRIANGLE INC (HCTI) has a profitability rating of 1 / 10.

How financially healthy is HEALTHCARE TRIANGLE INC?

The financial health rating of HEALTHCARE TRIANGLE INC (HCTI) is 3 / 10.

HEALTHCARE TRIANGLE INC (HCTI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

HEALTHCARE TRIANGLE INC / HCTI FAQ

Can you provide the ChartMill fundamental rating for HEALTHCARE TRIANGLE INC?

Can you provide the valuation status for HEALTHCARE TRIANGLE INC?

How profitable is HEALTHCARE TRIANGLE INC (HCTI) stock?

How financially healthy is HEALTHCARE TRIANGLE INC?